Boomerang Medical raises $20 million Series B co-led by Arboretum Ventures and Hatteras Venture Partners to advance its pivotal trial for neuromodulation in inflammatory bowel disease.
Amount Raised
$20 Million
Round Type
Series B
Investors
Description
Boomerang Medical, a women-led bioelectronic medicine company, announced a $20 million Series B financing co-led by Arboretum Ventures and Hatteras Venture Partners. The proceeds will advance the BOOM-IBD2 trial, focused on ulcerative colitis. Patients are currently being enrolled at leading medical centers across the U.S. to evaluate the potential of neuromodulation in managing symptoms.
Quick answer
Boomerang Medical raised $20 Million in a Series B round, dated September 4, 2025. Investors: Arboretum Ventures and Hatteras Venture Partners. Boomerang Medical is based in Mountain View, California, United States.
- How much did Boomerang Medical raise?
- Boomerang Medical raised $20 Million in a Series B round on September 4, 2025.
- Who invested in Boomerang Medical?
- Arboretum Ventures and Hatteras Venture Partners are named as investors in this round.
- What does Boomerang Medical do?
- Boomerang Medical is a women-led clinical-stage company headquartered on the campus of El Camino Hospital in Mountain View, California.
- Where is Boomerang Medical based and how big is it?
- Boomerang Medical is based in Mountain View, California, United States.
- Who are the decision-makers at Boomerang Medical?
- Fundz holds 1 contact at Boomerang Medical. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Boomerang Medical that raised within 45 days of this round, from Fundz verified event records.
- Theriva Biologics raised $13M on October 17, 2025.
- Adcytherix raised $122M (Series A) on October 16, 2025.
- Bexorg raised $23M (Series A) on October 16, 2025.
- Theriva Biologics raised $4M (Funding Round) on October 16, 2025.
- BeSound raised $6.8M (Seed) on October 15, 2025.
- Tubulis raised $358M (Series C) on October 15, 2025.
Who to call at Boomerang Medical, and when
A new round usually means Boomerang Medical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Boomerang Medical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Boomerang Medical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Boomerang Medical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Boomerang Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBoomerang Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.